Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this clinical trial is to find out how the study drug HHK001 compares toEnantone (an approved treatment for endometriosis) when given as a single 3.75 mginjection to participants with endometriosis. Both products contain the same activeingredient: leuprorelin acetate. We will check how the body absorbs and responds to eachmedicine, monitor possible side effects and treatment benefits.Researchers will compare HHK001 to Enantone to test the advantages of its updatedformulation.
Epistemonikos ID: 323ca2b304a9cad68d1de6edae6cbb132952346a
First added on: Aug 11, 2026